ADC Therapeutics SA (NYSE:ADCT) IPO
IPO
Priced at US$19.00 a share on May 14, 2020.
- Price
- US$19.00 a share
- Shares offered
- 12,245,631 common shares
- Offering size
- US$232.7 million
- Underwriters' option
- Up to 1,836,844 more shares
- Listing
- ADCT on the New York Stock Exchange
- Underwriters
- MORGAN STANLEY, BofA SECURITIES, COWEN · In the order on the cover
- Shares delivered
- On or about May 19, 2020
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Mar 2, 2020 |
| Filed publicly | Apr 24, 2020 |
| Amended 3 times | Newest May 14, 2020 |
| Shares registered with an exchange | May 11, 2020 |
| Declared effective by the SEC | May 14, 2020 |
| Final prospectus, with the price | May 18, 2020 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | May 18, 2020 |
| EFFECT · Notice that a registration is effective | May 14, 2020 |
| F-1MEF · Registration of more shares for the same offering | May 14, 2020 |
| F-1/A · Registration statement, amended | May 14, 2020 |
| CERT · Exchange's certificate of listing | May 12, 2020 |
| CORRESP · Letter to the SEC | May 12, 2020 |
| CORRESP · Letter to the SEC | May 12, 2020 |
| 8-A12B · Registration of shares for listing on an exchange | May 11, 2020 |
| F-1/A · Registration statement, amended | May 11, 2020 |
| CORRESP · Letter to the SEC | Apr 28, 2020 |
| F-1/A · Registration statement, amended | Apr 27, 2020 |
| F-1 · Registration statement | Apr 24, 2020 |
| UPLOAD · Letter from the SEC | Mar 25, 2020 |
| DRSLTR · Letter to the SEC with a draft | Mar 2, 2020 |
| DRS · Draft registration statement | Mar 2, 2020 |
From the cover of the final prospectus (424B4) filed May 18, 2020